Gigi Schumm Joins ThreatQuotient as Worldwide Sales SVP; John Czupak Comments

Gigi Schumm

Gigi Schumm, a founding partner of Accelerated Government Strategies, has been named senior vice president of worldwide sales at Reston, Virginia-based cybersecurity firm ThreatQuotient.

ThreatQuotient said Wednesday Schumm brings more than 25 years of sales and services experience to her new position and aims to help drive the company’s revenue growth and global channel strategy.

“Gigi’s track record of success and demonstrated understanding of the cybersecurity industry makes her a great asset for ThreatQuotient’s go-to-market strategy of both direct and channel partner sales,” CEO John Czupak said.

Schumm has co-hosted Federal News Radio’s “Women of Washington” weekly program since 2014.

She previously held various leadership roles at Apple, Oracle, Sun Microsystems and Symantec.

You may also be interested in...

ERAPSCO

ERAPSCO to Produce AN/SSQ-125 Sonobuoys Under $71M Navy Contract Modification

A joint venture between Ultra Electronics and Sparton has landed a two-year, $71.3 million contract modification to manufacture and deliver up to 20,000 anti-submarine warfare acoustic sensors to the U.S. Navy.

Leidos

Leidos Awarded $58M Contract Modification to Help DISA Update Artillery Tactical Data Systems

Leidos has secured a $58 million contract modification from the Defense Information Systems Agency to continue its work to modernize systems that automate artillery operations. The company will use a revised code convergence strategy to update the Advanced Field Artillery Tactical Data Systems, the Department of Defense said Wednesday.

Avenger ER General Atomics

FAA Certifies General Atomics-Made Extended Range Drone for Testing in US Airspace

General Atomics' aeronautical systems business has received the Federal Aviation Administration's approval to test a second Avenger Extended Range unmanned aircraft system in U.S. national airspace. The company said Wednesday it will use the FAA-granted experimental certificate to expand Avenger ER's testing activities for internal research and development, as well as contracted efforts.